Western blots showed that 24 h DFO and DFX treatment markedly decreased the expression of cyclin D1 and cyclin-dependent kinase 4 (CDK4) in osteosarcoma cells, but CDK4 expression not significantly decreased in K7M2 cell. The gene discussed is CDK4; the disease is osteosarcoma.